Programme | n† | Age (years) at baseline | FEV1 (L) at baseline | Height (cm) at baseline | Mean duration of follow-up (years) |
P1- Male | 159 | 37 (10.0) | 4.2 (0.8) | 176 (5.9) | 5.2 |
Female | 37 | 34 (7.7) | 3.1 (0.6) | 162 (5.3) | 5.1 |
P2- Male | 714 | 37 (11.1) | 3.9 (0.7) | 179 (6.6) | 5.4 |
Female | 111 | 35 (9.5) | 2.8 (0.6) | 167 (6.8) | 3.8 |
P3A-Male | 1291 | 38 (9.9) | 4.2 (0.7) | 179 (10.3) | 8.4 |
Female | 49 | 32 (4.2) | 3.6 (0.4) | 170 (4.9) | 7.8 |
P3B-Male | 1213 | 40 (10.7) | 4.1 (0.7) | 178 (11.3) | 3.5 |
Female | 53 | 35 (6.4) | 3.4 (0.5) | 170 (5.1) | 3.2 |
P4-Male | 3510 | 48 (7.0) | 2.9 (0.5) | 177 (6.6) | 4.9 |
Female | 2087 | 49 (6.6) | 2.1 (0.4) | 164 (5.9) | 4.9 |
†Number of individuals who had at least one follow-up measurement within 14 months.